Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Proc Soc Exp Biol Med ; 220(3): 139-46, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10193441

RESUMO

The effects of hypothalamic lesions designed to destroy either the anterior median eminence (ME) or the posterior and mid-ME on pulsatile release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were determined in castrated male rats. In sham-operated animals, mean plasma FSH concentrations rose to peak at 10 min after the onset of sampling, whereas LH declined to a nadir during this time. In the final sample at 120 min, the mean FSH concentrations peaked as LH decreased to its minimal value. In rats with anterior ME lesions, there was suppression of LH pulses with continuing FSH pulses in 12 of 21 rats. On the other hand, in animals with posterior to mid-ME lesions, 3 out of 21 rats had elimination of FSH pulses, whereas LH pulses were maintained. Fifteen of 42 operated rats had complete ME lesions, and pulses of both hormones were abolished. The remaining 12 rats had partial ME lesions that produced a partial block of the release of both hormones. The results support the concept of separate hypothalamic control of FSH and LH release with the axons of the putative FSH-releasing factor (FSHRF) neuronal system terminating primarily in the mid- to caudal ME, whereas those of the LHRH neuronal system terminate in the anterior and mid-median eminence. We hypothesize that pulses of FSH alone are mediated by release of the FSHRF into the hypophyseal portal vessels, whereas those of LH alone are mediated by LHRH. Pulses of both gonadotropins simultaneously may be mediated by pulses of both releasing hormones simultaneously. Alternatively, relatively large pulses of LHRH alone may account for simultaneous pulses of both gonadotropins since LHRH has intrinsic FSH-releasing activity.


Assuntos
Hormônio Foliculoestimulante/metabolismo , Hormônio Luteinizante/metabolismo , Eminência Mediana/fisiologia , Animais , Peso Corporal , Hormônio Foliculoestimulante/sangue , Hormônio Liberador de Gonadotropina/fisiologia , Gonadotropinas Hipofisárias/metabolismo , Hormônio Luteinizante/sangue , Masculino , Eminência Mediana/anatomia & histologia , Eminência Mediana/lesões , Neurônios/metabolismo , Orquiectomia , Tamanho do Órgão , Hipófise/anatomia & histologia , Hipófise/metabolismo , Ratos , Ratos Sprague-Dawley
2.
Clin Exp Hypertens ; 17(6): 977-88, 1995 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7581264

RESUMO

We investigated the genesis of the hypertensive response to acute (45 min) aortic constriction in two models of chronic vasopressin (AVP) deficiency, i.e., Brattleboro strain and median eminence lesioned (MEL) Wistar rats. The same degree of partial aortic constriction, with a pneumatic cuff placed around the abdominal aorta, yielded a sudden and maintained increase in carotid pressure to the same extent in Brattleboro, MEL and sham-MEL rats. Blockage of AVP V1 receptors with d(CH2)5Tyr[Me]AVP did not affect the hypertensive response of Brattleboro or MEL rats, but gradually blunted the response of sham-MEL rats. Blockage of angiotensin II receptors with saralasin blunted the hypertensive response of the AVP-deficient subjects throughout the experiment, but only delayed (5-15 min) the onset of hypertension in sham-MEL rats. Simultaneous blockage of AVP and angiotensin II blunted the hypertensive response of sham-MEL and AVP-deficient rats throughout the experiment. These data demonstrate that when one vasoactive system is chronically absent, as is the case for AVP in Brattleboro and MEL rats, the renin-angiotensin system plays the major role in the pathophysiology of acute aortic coarctation hypertension.


Assuntos
Coartação Aórtica/complicações , Arginina Vasopressina/deficiência , Hipertensão/etiologia , Antagonistas de Receptores de Angiotensina , Animais , Antagonistas dos Receptores de Hormônios Antidiuréticos , Coartação Aórtica/fisiopatologia , Arginina Vasopressina/análogos & derivados , Arginina Vasopressina/farmacologia , Arginina Vasopressina/fisiologia , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Doença Crônica , Feminino , Antagonistas de Hormônios/farmacologia , Hipertensão/fisiopatologia , Masculino , Eminência Mediana/lesões , Ratos , Ratos Brattleboro , Ratos Wistar , Sistema Renina-Angiotensina/fisiologia , Saralasina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA